Viruses have played con-man to tissues and immune systems for a long time. By harnessing these capabilities, researchers are attempting to create nanoreactors and better therapeutic vehicles. Image Source: Wikimedia Commons User Splette Viruses are a non-living anomaly in the microscopic world; they make a living out of hijacking a […]
Recent developments in biologic therapies may bring an end to the off-label use of chemotherapy and other salvage therapies in hemophagocytic lymphohistiocytosis. Image Source: Wikimedia Commons user: Bill Branson Cancer may be the darling of the research world, but there are other, rarer diseases that require just as much care […]
As life science firms look for patient populations to help by designing novel biotherapeutics, they will need to ensure their research efforts allow for efficient drug discovery and development.
Companies can prepare to compete with biosimilars by adopting a simple, yet effective, strategy: innovation. By developing drugs that improve upon earlier iterations, companies can continue to protect their market advantage from lower-cost generic versions.
There is a growing need for more efficacious retinal degenerative disease treatment as the population ages and there is mounting exposure to common causes.
There is a growing body of research highlighting the unique properties of cancer stem cells and scientists can use this information to design biologic drugs that exploit CSC properties in order to provide more effective treatment strategies for cancer.
The FDA approved an active hemostatic agent called Raplixa for use in surgery in April 2015. Hemostatic agents may be considered either mechanical or active. Mechanical agents prevent bleeding by forming a mechanical barrier, whereas active hemostats contain active biological materials.
Cancer cells are often present in the body without ever turning into full-blown cancer. In theory, the body has natural mechanisms which seek out and destroy cancer cells. It truly becomes “cancer” when cancer cells are able to evade immune detection and destruction, and set up camp within the body. […]
In mid-June, researchers reported that they were able to use next-generation sequencing to diagnose suspected brain infections, which are often arduous and complicated to diagnose. After taking biopsies of brain lesions, a metagenomic analysis was performed on the tissue. In a number of the patients, this lead to individualized precision treatment based on the bacteria identified. With all of the specialized disciplines surrounding populations of cells/organisms and the functioning parts within cells, researchers have multitudes of information at their disposal—now what?
It’s 1995 in the Democratic Republic of Congo, and a man is infected with the Ebola virus. Years later scientists would draw his blood and begin to analyze the antibodies in the sample, hoping to find information leading to a cure for Ebola. Now, the recently published results of this […]